WA Hepatitis B Strategy – research, evaluation and surveillance

Understand disease burden

Understanding of the burden of disease attributable to hepatitis B and the associated risk factors will be improved through:

  • continuing to make regular epidemiological data available to inform service planning and implementation
  • continued support of, and participation in, relevant national research projects.

Evaluate public health response

The public health response to hepatitis B will be evaluated to assess the impact of these programs on decreasing the morbidity and mortality associated with hepatitis B.

Key initiatives will include:

  • building organisational competence in evaluating hepatitis B programs and activities
  • building research and evaluation into the development of new programs
  • sharing research and evaluation findings across the sector to inform future planning and projects.
Icon: Links to WA Hepatitis B Strategy 2015–2018 – prevention and education Icon: Links to WA Hepatitis B Strategy 2015–2018 – testing and diagnosis Icon: Links to WA Hepatitis B Strategy 2015–2018 – disease management and clinical care
Icon: Links to WA Hepatitis B Strategy 2015–2018 – workforce development Icon: Links to WA Hepatitis B Strategy 2015–2018 – enabling environment Icon: Links to WA Hepatitis B Strategy 2015–2018 – research, evaluation and surveillance

Monitoring and evaluation

Progress against the WA Hepatitis B Strategy 2015–2018 will be collated in the WA Hepatitis B Strategy 2015–2018 – Monitoring and Evaluation Framework. This will be updated regularly.

Produced by

Public Health